Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H19NO3 |
Molecular Weight | 285.3377 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(\C=C/C=C\C1=CC2=C(OCO2)C=C1)N3CCCCC3
InChI
InChIKey=MXXWOMGUGJBKIW-PORYWJCVSA-N
InChI=1S/C17H19NO3/c19-17(18-10-4-1-5-11-18)7-3-2-6-14-8-9-15-16(12-14)21-13-20-15/h2-3,6-9,12H,1,4-5,10-11,13H2/b6-2-,7-3-
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/26560940 | https://www.ncbi.nlm.nih.gov/pubmed/26146123Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/23625885
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26560940 | https://www.ncbi.nlm.nih.gov/pubmed/26146123
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/23625885
Piperine is a simple and pungent alkaloid found in the seeds of black pepper (Piper nigrum). Following its isolation and full characterization, the biological properties of piperine have been extensively studied, and piperine-like derivatives have shown an interesting range of pharmacological activities. Piperine is currently paving its way to become a privileged scaffold for the development of bioactive compounds with therapeutic application in multiple human diseases. In particular, piperine derivatives were shown to modulate the activity of several targets related to neurological disorders, including epilepsy, Parkinson's disease, depression and pain related disorders. Moreover, the efflux pump inhibitory ability of piperine and its analogues tackles important drug resistance mechanisms and may improve the clinical efficacy of antibiotic and anticancer drugs. Piperine has been found to have immunomodulatory, anti-oxidant, anti-asthmatic, anti-carcinogenic, anti-inflammatory, anti-ulcer, and anti-amoebic properties.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27018328
Curator's Comment: Blood-brain barrier penetrant and CNS active
Originator
Sources: http://learnpiperine.weebly.com/history.html
Curator's Comment: Piperine was discovered in 1819, when Hans Christian Ørsted isolated it from the fruits of the source plant of black and white pepper, piper nigrum. Piperine's chemical constitution was established by laboritory synthesis in 1882 and 1894.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3356 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27821437 |
14.19 µM [IC50] | ||
Target ID: CHEMBL340 |
2.12 µM [IC50] | ||
Target ID: map04010 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25471891 |
|||
Target ID: CHEMBL2321614 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24302912 |
133.3 µM [IC50] | ||
Target ID: CHEMBL2321613 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24302912 |
45.0 µM [IC50] | ||
Target ID: CHEMBL2331042 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24302912 |
230.7 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Action of intrathecal capsaicin and its structural analogues on the content and release of spinal substance P: selectivity of action and relationship to analgesia. | 1984 Jul 23 |
|
The plant alkaloid piperine as a potential inhibitor of ethidium bromide efflux in Mycobacterium smegmatis. | 2011 Feb |
|
Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCα/ERK1/2-dependent matrix metalloproteinase-9 expression. | 2011 May 30 |
|
Piperine potentiates the antidepressant-like effect of trans-resveratrol: involvement of monoaminergic system. | 2013 Dec |
|
Piperine blocks interleukin-2-driven cell cycle progression in CTLL-2 T lymphocytes by inhibiting multiple signal transduction pathways. | 2015 Apr 2 |
|
Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. | 2015 Jan 5 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27670974
A single dose of Piperine 20 mg was administered daily for 10 days
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25471891
Piperine inhibited the proliferation of SW480 and HT-29 cells in a dose-dependent manner, it had low cytotoxicity on these cell lines with 50 % inhibiting concentration (IC50) values greater than 100 uM. Pretreatment of the cells with 40 uM piperine for 1 h significantly
inhibited the mRNA production of CXCL8 in response to LPS stimulation in SW480 and HT-29 cells.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1548912
Created by
admin on Sat Dec 16 00:22:48 GMT 2023 , Edited by admin on Sat Dec 16 00:22:48 GMT 2023
|
PRIMARY | |||
|
495-91-0
Created by
admin on Sat Dec 16 00:22:48 GMT 2023 , Edited by admin on Sat Dec 16 00:22:48 GMT 2023
|
PRIMARY | |||
|
DTXSID301023602
Created by
admin on Sat Dec 16 00:22:48 GMT 2023 , Edited by admin on Sat Dec 16 00:22:48 GMT 2023
|
PRIMARY | |||
|
m3318
Created by
admin on Sat Dec 16 00:22:48 GMT 2023 , Edited by admin on Sat Dec 16 00:22:48 GMT 2023
|
PRIMARY | Merck Index | ||
|
95JV386FPD
Created by
admin on Sat Dec 16 00:22:48 GMT 2023 , Edited by admin on Sat Dec 16 00:22:48 GMT 2023
|
PRIMARY | |||
|
CHAVICINE
Created by
admin on Sat Dec 16 00:22:48 GMT 2023 , Edited by admin on Sat Dec 16 00:22:48 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD